Advanced Cell Diagnostics’ Pharma Assay Services (PAS) provides RNAscope® ISH in situ gene expression analysis for target validation, target safety assessment and biomarker discovery to support preclinical research in every therapeutic area, as well as clinical biomarker development for oncology. We provide access to expertise directly from RNAscope® technology developers, as well as early access to the latest product innovations.
With over five years of experience as a contract research organization (CRO) specializing in RNAscope® ISH, we have supported hundreds of clinical and pre-clinical projects with every major biopharma in the United States and globally. Each project is individually tailored and managed by our team of scientists, specialists, board certified pathologists, and data experts
- 10,000+ slides delivered per year
- 500+ target-specific tissue expression assays validated and successfully performed
- 150+ tissue types including normal human, clinical disease specimens, preclinicalmodels, humanized mouse and syngeneic mouse tumor models
- 8 automated staining systems from Leica Biosystems and Ventana Medical Systems